200 related articles for article (PubMed ID: 21763254)
1. Polymorphisms in CCR6 are associated with chronic graft-versus-host disease and invasive fungal disease in matched-related hematopoietic stem cell transplantation.
Broen K; van der Waart AB; Greupink-Draaisma A; Metzig J; Feuth T; Schaap NP; Blijlevens NM; van der Velden WJ; Dolstra H
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1443-9. PubMed ID: 21763254
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
[TBL] [Abstract][Full Text] [Related]
3. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
Elmaagacli AH; Koldehoff M; Landt O; Beelen DW
Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
[TBL] [Abstract][Full Text] [Related]
4. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
[TBL] [Abstract][Full Text] [Related]
5. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.
Gruhn B; Intek J; Pfaffendorf N; Zell R; Corbacioglu S; Zintl F; Beck JF; Debatin KM; Steinbach D
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1571-7. PubMed ID: 19896081
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
Murphy N; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King B; Macgregor L; Holdsworth R; McCluskey J; Tait BD
Bone Marrow Transplant; 2006 Apr; 37(8):773-9. PubMed ID: 16518429
[TBL] [Abstract][Full Text] [Related]
9. [IL-18 single nucleotide polymorphisms in hematologic malignancies with HLA matched sibling donor allogeneic hematopoietic stem cell transplantation].
Cai X; Song A; Wang H; Zhang P; Zhang G; Yang F; Wei J; Ma Q; Yan Z; Jiang E; Huang Y; Yang D; Wang M; He Y; Han M; Feng S
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):215-20. PubMed ID: 24666487
[TBL] [Abstract][Full Text] [Related]
10. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Viel DO; Tsuneto LT; Sossai CR; Lieber SR; Marques SB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA; Visentainer JE
Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
[TBL] [Abstract][Full Text] [Related]
11. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
Elmaagacli AH; Koldehoff M; Hindahl H; Steckel NK; Trenschel R; Peceny R; Ottinger H; Rath PM; Ross RS; Roggendorf M; Grosse-Wilde H; Beelen DW
Transplantation; 2006 Jan; 81(2):247-54. PubMed ID: 16436969
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
[TBL] [Abstract][Full Text] [Related]
13. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation.
Granell M; Urbano-Ispizua A; Suarez B; Rovira M; Fernández-Avilés F; Martínez C; Ortega M; Uriburu C; Gaya A; Roncero JM; Navarro A; Carreras E; Mensa J; Vives J; Rozman C; Montserrat E; Lozano F
Exp Hematol; 2006 Oct; 34(10):1435-41. PubMed ID: 16982337
[TBL] [Abstract][Full Text] [Related]
14. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
[TBL] [Abstract][Full Text] [Related]
15. Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population.
Laguila Visentainer JE; Lieber SR; Lopes Persoli LB; Dutra Marques SB; Vigorito AC; Penteado Aranha FJ; de Brito Eid KA; Oliveira GB; Martins Miranda EC; Bragotto L; de Souza CA
Cytokine; 2005 Nov; 32(3-4):171-7. PubMed ID: 16243534
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
[TBL] [Abstract][Full Text] [Related]
17. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
[TBL] [Abstract][Full Text] [Related]
18. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation.
Takahashi H; Furukawa T; Hashimoto S; Suzuki N; Kuroha T; Yamazaki F; Inano K; Takahashi M; Aizawa Y; Koike T
Bone Marrow Transplant; 2000 Dec; 26(12):1317-23. PubMed ID: 11223972
[TBL] [Abstract][Full Text] [Related]
19. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
Elbahlawan L; McArthur J; Quasney MW; Pei D; Srivastava K; Dahmer MK; Barfield R
J Pediatr Hematol Oncol; 2012 Apr; 34(3):175-9. PubMed ID: 22395218
[TBL] [Abstract][Full Text] [Related]
20. ATM gene single nucleotide polymorphisms predict regimen-related gastrointestinal toxicity in patients allografted after reduced conditioning.
Kuba A; Raida L; Mrazek F; Schneiderova P; Kriegova E; Furst T; Furstova J; Faber E; Ambruzova Z; Papajik T
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1136-40. PubMed ID: 25759145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]